XRP44X Enhances the Cytotoxic Activity of Natural Killer Cells by Activating the c-JUN N-Terminal Kinase Signaling Pathway.

XRP44X Enhances the Cytotoxic Activity of Natural Killer Cells by Activating the c-JUN N-Terminal Kinase Signaling Pathway.

natural killer (NK) cells of the innate lymphocytes that play an important role in preventing the development of cancer by monitoring immune system to eradicate the abnormal cells. Since the ex vivo expanded NK cell cytotoxic activity against a variety of cancers, including breast cancer, their clinical potential as an immune-oncogenic therapy has been studied … Read more